Active ingredient
Tafluprost
5 finished FDA listings contain Tafluprost as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- TAFLUPROST
- Dosage forms
- Solution/ Drops
- Routes
- Ophthalmic
- Manufacturers / labelers
- 5
- Strengths listed
- .0045 mg/.3ml · .015 mg/ml
- Brand names in FDA listings
- Tafluprost, Tafluprost Ophthalmic, Zioptan
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1244607
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 202514 | THEA PHARMA | 2012-02-10 | 2 |
| ANDA 209051 | MICRO LABS | 2019-08-19 | 1 |
| ANDA 209040 | SANDOZ | 2022-01-28 | 1 |
| ANDA 218002 | INGENUS PHARMS LLC | 2024-04-05 | 1 |
Official labeling on DailyMed
- TAFLUPROST SOLUTION/ DROPS [SANDOZ INC] · version 13 · 2026-09-07
- ZIOPTAN (TAFLUPROST) SOLUTION/ DROPS [THEA PHARMA INC.] · version 7 · 2026-05-06
- TAFLUPROST (TAFLUPROST OPTHALMIC) SOLUTION/ DROPS [MICRO LABS LIMITED] · version 6 · 2026-03-09
- TAFLUPROST SOLUTION/ DROPS [INGENUS PHARMACEUTICALS, LLC] · version 7 · 2024-12-19
- TAFLUPROST OPHTHALMIC (TAFLUPROST) SOLUTION/ DROPS [PRASCO LABORATORIES] · version 1 · 2022-11-18
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.